"It was particularly interesting to learn what lasting impacts a GLP-1 medication may have on consumers they continue to try to maintain those healthy eating habits even as the 'food noise' returns." "As a result of the study, we have identified key implications for brands and retailers regarding product prioritizations and how we can best convey product benefits to support weight loss journeys, both during and post GLP-1 therapy," said Jami McDermid, president, CROSSMARK Sales Agency, a division of Acosta Group
Concerns about lean mass loss and metabolism Clinical data shows semaglutide can reduce lean body mass, with losses ranging from nearly 0% to 40% of total weight reduction
If you use a pre-filled pen, ensure the pen is ready and the needle is attached if required
The bigger picture: choosing the right semaglutide provider WeightCare is one option in a crowded market
Phentermine in the past was prescribed for short-term use, and now has a place for longer term management to prevent weight re-gain